Drug Discovery World

DECEMBER 19, 2023

The patient was dosed without the need for a chemotherapy (required for gene modified stem cells) or immunosuppression (required for systemic virus-delivered gene therapy).

Engineering 284

Engineering Therapies Trials Medical Schools 284

Drug Discovery World

NOVEMBER 22, 2023

Polyak is a professor of medicine at Harvard Medical School and the Dana-Farber Cancer Institute. This award was established to recognise outstanding science that has inspired, or has the potential to inspire, new perspectives on the etiology, diagnosis, treatment, or prevention of breast cancer.

Research 147

Research Medical Schools Science Treatment 147

Drug Discovery World

FEBRUARY 8, 2024

Catherine Brownstein is an Assistant Professor in Pediatrics at Harvard Medical School and the Assistant Director of the Molecular Genetics Core Facility at Boston Children’s Hospital. This is episode five, Solving the diagnostic odyssey with multi-omics.

Medical Schools 147

Medical Schools Hospitals Drugs 147

Drug Discovery World

FEBRUARY 8, 2024

Catherine Brownstein is an Assistant Professor in Pediatrics at Harvard Medical School and the Assistant Director of the Molecular Genetics Core Facility at Boston Children’s Hospital. This is episode five, Solving the diagnostic odyssey with multi-omics.

Medical Schools 130

Medical Schools Hospitals Drugs 130

Drug Discovery World

DECEMBER 6, 2023

“The findings of our study reimagine osteoarthritis not as a ‘wear and tear’ condition but as an active, and pharmaceutically reversible loss of critical articular cartilage stem cells,” said the University of Adelaide’s Dr Jia Ng from the Adelaide Medical School, who co-led the study.

Medical Schools 264

Medical Schools Clinical Trials Pharmaceuticals Trials 264

Drug Discovery World

FEBRUARY 2, 2023

In the second article, Dr David Walt, a professor at Harvard Medical School who runs labs at both Brigham and Women’s Hospital and the Wyss Institute at Harvard University, shares his thoughts on the drug discovery industry and what the pandemic has taught us about lab automation.

Medical Schools 246

Medical Schools Hospitals Drugs DNA 246

Drugs.com

APRIL 1, 2024

MONDAY, April 1, 2024 -- In a letter sent to teaching hospitals and medical schools across the country, the U.S. Department of Health and Human Services said Monday that written consent must be obtained from patients before performing sensitive.

Hospitals 76

Hospitals Medical Schools 76

Drug Discovery World

APRIL 1, 2024

Although some cell lines exhibited too much activity in this mTOR pathway, while others exhibited too little, the researchers could correct both problems and spur better cell differentiation with existing drugs that either stimulate or inhibit the activity of mTOR (mechanistic target of rapamycin).

Medical Schools 147

Medical Schools Cell Biology Regulations Research 147

Drug Discovery World

OCTOBER 13, 2023

Researchers at Harvard Medical School (HMS) in the US and the University of Oxford have developed a new artificial intelligence (AI) tool named EVEscape that can predict new viral variants before they emerge.

Vaccine 264

Vaccine Virus Medical Schools Immune Response 264

Drug Discovery World

MARCH 7, 2024

But it is only now, with advancements in AI, that we have been able to show that there are actually two different subtypes at play,” said Professor Colin Cooper, from UEA’s Norwich Medical School.

Disease 147

Disease Medical Schools DNA International 147

Drug Discovery World

FEBRUARY 6, 2024

Catherine Brownstein is an Assistant Professor in Pediatrics at Harvard Medical School and the Assistant Director of the Molecular Genetics Core Facility at Boston Children’s Hospital. Her current work focuses on advancing the fields of genome sequencing and analysis, with an emphasis on identifying complex structural variation.

Medical Schools 147

Medical Schools Clinical Trials Assay Development Hospitals 147

Drug Discovery World

JANUARY 26, 2023

Scientists may have discovered clues to why cancer cells can avoid the body’s immune system in a study conducted by researchers at Harvard Medical School. With further research, the team at Harvard Medical School hope that more targeted therapies can be developed to treat cancers whose growth is fuelled by this metabolite.

Medical Schools 130

Medical Schools Cell Biology Research Therapies 130

Drug Discovery World

NOVEMBER 28, 2023

The peer-reviewed article titled ‘Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson’s disease (PD) mouse model’ was the result of collaborative work between Cambridge University, Harvard Medical School, and Mission Therapeutics.

Disease 130

Disease Therapies Medical Schools Trials 130

Drug Discovery World

AUGUST 25, 2023

Paul Schulz, the Rick McCord Professor in Neurology with McGovern Medical School at UTHealth Houston, was senior author of the study. Over the last couple of years, the field of AD has vastly expanded, especially with the recent approval of anti-amyloid antibody medications by the FDA.

Vaccine 130

Vaccine Medical Schools Immune Response Disease 130

Drug Discovery World

MARCH 21, 2023

“We believe we have developed the first technology to design an organism that can’t be infected by any known virus,” said the study’s first author, Akos Nyerges, research fellow in genetics in the lab of George Church in the Blavatnik Institute at Harvard Medical School and the Wyss Institute for Biologically Inspired Engineering. “We

Engineering 130

Engineering Virus Research Medical Schools 130

SCIENMAG: Medicine & Health

NOVEMBER 17, 2023

The Anthem Rural Medicine Scholarships will provide $100,000 to offset the cost of medical school for students in the RPLP. Credit: […]

Medical Schools 83

Medical Schools 83

SCIENMAG: Medicine & Health

JANUARY 17, 2024

Long-Jiang Zhang (Department of Radiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University) and Prof. This review was jointly published by Prof.

Medical Schools 67

Medical Schools Hospitals Science 67

Drug Discovery World

FEBRUARY 2, 2023

In the second article, Dr David Walt, a professor at Harvard Medical School who runs labs at both Brigham and Women’s Hospital and the Wyss Institute at Harvard University, shares his thoughts on the drug discovery industry and what the pandemic has taught us about lab automation.

Medical Schools 130

Medical Schools Hospitals Drugs 130

Drug Discovery World

OCTOBER 13, 2023

Professor David Strain, the clinical lead based at the University of Exeter Medical School, said: “Inflammation in the body and brain are closely associated with symptoms of long Covid. The first phase of research will begin in January 2024 and will look at a series of measures, including exercise tolerability.

Medical Schools 147

Medical Schools Hospitals Virus Treatment 147

Drug Discovery World

JULY 21, 2022

Dr Elsie Horne, Senior Research Associate in Medical Statistics and Health Data Science in?Bristol Bristol Medical School: Population Health Sciences (PHS)?and Official comments. This finding was consistent across all adults, including older adults and those who are at risk of severe Covid-19.” .

Vaccine 130

Vaccine Medical Schools Hospitals Science 130

Drug Discovery World

DECEMBER 8, 2022

Lori Laffel, Principal Investigator of the DINAMO study and Chief of the Pediatric, Adolescent, and Young Adult Section at the Joslin Diabetes Center and Professor of Pediatrics at Harvard Medical School, said: “These findings are particularly important given the need for more therapeutic options, especially oral agents, to manage type 2 diabetes in (..)

Trials 130

Trials Medical Schools Clinical Trials International 130

Drug Discovery World

JANUARY 5, 2023

CANbridge Pharmaceuticals has exercised its option to secure the exclusive global rights to develop, manufacture and commercialise a novel gene therapy to treat spinal muscular atrophy (SMA) from UMass Chan Medical School. . It also exhibited much less liver toxicity when administered intravenously. .

Therapies 130

Therapies Medical Schools Clinical Development Pharmaceuticals 130

Drug Discovery World

MAY 8, 2024

“No medication has been approved by the FDA for vaping cessation in the United States,” said lead author Nancy Rigotti, Director of Massachusetts General Hospital’s Tobacco Research and Treatment Center and a Professor of Medicine at Harvard Medical School.

Clinical Trials 182

Clinical Trials Compliance Trials Drugs 182

Drug Discovery World

JULY 3, 2023

I find these data encouraging, as they suggest the possibility of providing families with an effective, non-surgical HDFN treatment option if approved.”

Trials 130

Trials Medical Schools Clinical Development Treatment 130

Drug Discovery World

APRIL 24, 2023

Hosted by DDW and supported by Tecan, “How next-generation sequencing is informing oncology drug discovery” will be free to attend at 7AM PST / 10AM EST / 3PM BST / 4PM CET. You will hear from Darrell Green, a lecturer in RNA Biology at Norwich Medical School, Panna Sharma, CEO of Lantern Pharma, as well as Dr Stephane Budel and Dr Miguel Edwards, (..)

RNA 130

RNA Medical Schools Clinical Trials Drugs 130

Drug Discovery World

APRIL 18, 2023

Hosted by DDW and supported by Tecan, “How next-generation sequencing is informing oncology drug discovery” will be free to attend on April 24 at 7AM PST / 10AM EST / 3PM BST / 4PM CET. You will hear from Darrell Green, a lecturer in RNA Biology at Norwich Medical School, Panna Sharma, CEO of Lantern Pharma, as well as Dr Stephane Budel and Dr (..)

RNA 130

RNA Medical Schools Clinical Trials Drugs 130

Drug Discovery World

AUGUST 2, 2023

These models would create another avenue to predict disease and study treatment on a personalised level for conditions that often vary greatly from person to person.”

Research 130

Research Medical Schools Engineering Disease 130

Drug Discovery World

APRIL 11, 2023

Hosted by DDW and supported by Tecan, “How next-generation sequencing is informing oncology drug discovery” will be free to attend on April 24 at 7AM PST / 10AM EST / 3PM BST / 4PM CET. You will hear from Darrell Green, a lecturer in RNA Biology at Norwich Medical School, Panna Sharma, CEO of Lantern Pharma, as well as Dr Stephane Budel and Dr (..)

RNA 130

RNA Medical Schools Clinical Trials Drugs 130

Drug Discovery World

APRIL 4, 2023

Join this free webinar to learn about the biggest challenges and opportunities facing the NGS oncology space. You will hear from Darrell Green, a lecturer in RNA Biology at Norwich Medical School, Panna Sharma, CEO of Lantern Pharma, as well as Dr Stephane Budel and Dr Miguel Edwards, Founding Partner and Partner at DeciBio.

RNA 130

RNA Medical Schools Drugs Clinical Trials 130

Drug Discovery World

APRIL 3, 2023

Join this free webinar to learn about the biggest challenges and opportunities facing the NGS oncology space. You will hear from Darrell Green, a lecturer in RNA Biology at Norwich Medical School, Panna Sharma, CEO of Lantern Pharma, as well as Dr Stephane Budel and Dr Miguel Edwards, Founding Partner and Partner at DeciBio.

RNA 130

RNA Medical Schools Clinical Trials Drugs 130

Drug Discovery World

FEBRUARY 2, 2023

The last endocrine therapy approved was about 20 years ago, and effective endocrine options for this patient population are needed,” said Dr Aditya Bardia, Director of Breast Cancer Research at Mass General Cancer Center, Associate Professor at the Medicine Department at Harvard Medical School, and Principal Investigator for the EMERALD trial. “ESR1 (..)

FDA Approval 130

FDA Approval Therapies FDA Medical Schools 130

Drug Discovery World

MAY 4, 2023

The research by investigators at Harvard Medical School and Dana-Farber Cancer Institute found that specific gut bacteria can affect the activity of two immune molecules – PD-L2 and RGMb – as well as the interplay between them.

Medical Schools 130

Medical Schools Small Molecule Research Treatment 130

Drug Discovery World

NOVEMBER 8, 2023

AI-enabled tumour profiling Furthermore, scientists from Harvard Medical School 8 have pioneered an AI tool named CHARM (Cryosection Histopathology Assessment and Review Machine), which deciphers the DNA of brain tumours in real-time during surgery. Harvard Medical School, 7 July 2023. Businesswire, 14 February 2023.

Clinical Trials 182

Clinical Trials Trials Disease Medical Schools 182

Drug Discovery World

DECEMBER 5, 2022

It was led by scientists at the MRC-University of Glasgow Centre for Virus Research (CVR) and University of Massachusetts Chan Medical School. . The research focuses on a group of small, ubiquitous viruses called ‘parvoviruses’ (from the Latin word ‘ parvus’ meaning ‘small’, ‘puny’ or ‘unimportant’).

Virus 130

Virus Therapies Treatment Medical Schools 130

Drug Discovery World

MARCH 15, 2023

First new treatment in 45 years Lead researcher Dr Darrell Green, from UEA’s Norwich Medical School, was inspired to study childhood bone cancer after his best friend died from the disease as a teenager. CADD522 is a small molecule which blocks the RUNX2 protein from having an effect.

Small Molecule 130

Small Molecule Medical Schools Drugs Clinical Trials 130

Drug Discovery World

NOVEMBER 11, 2022

ATO has previously received marketing approvals in the US and Europe for treatment of a rare cancer condition, acute promyelocytic leukaemia (APL). . The update from the company follows the announcement of a merger between Bone Therapeutics and Medsenic, and listing on Euronext Brussels and Paris. .

Disease 130

Disease Small Molecule Medical Schools Trials 130

Drug Discovery World

OCTOBER 26, 2022

“What we’ve done is exciting because there is potential for BanLec to develop into a broad spectrum antiviral agent, something that is not clinically available to physicians and patients right now,” said co-senior author Dr David Markovitz, Professor of Internal Medicine at the University of Michigan Medical School. .

Engineering 130

Engineering Virus Medical Schools International 130